Skip to content
GBC - Global BioClinical
  • Home
  • Company
    • Company Overview
    • Management Team
    • Director’s Message
    • “The Small Clinical Research Organization (CRO) Advantage”
    • Core Values
    • Memberships
    • Careers
    • Contact
  • Services
    • Consulting
      • Organizational Consulting
        • Organizations GBC Serves
      • Project Management
      • Quality Management
        • QMS Development
        • Audit Services
          • Organizations GBC Audits
      • Regulatory Support
      • Medical & Technical Writing
      • Medical & Scientific Liaison
    • Business
      • Business Intelligence
      • Strategic Alliances
        • Alliance Evaluation
        • Alliance Management
      • Business Development
      • Risk Management
      • Human Capital
    • Trials
      • Trial Strategy & Design
        • Types of Studies
        • Therapeutic Areas
        • Trial Globalization
      • Trial Preparation
      • Trial Launch
      • Site Management
      • Monitoring
      • Data Management
      • Study Supply Logistics
      • Adaptive Transition
      • Trial Close Out
    • Biospecimens
      • Sourcing
        • Common Indications
        • Common Formats
      • Biospecimen Management
      • Biorepository Management
      • Biorepository Accreditation
      • Cost Recovery
      • Tissue Research
  • Partners
    • Clients
    • Investigators
    • Industry Colleagues
  • Register
    • Registration
  • News & Events
    • In Vitro Diagnostics – IVD News
    • Press Releases
    • Events
    • GBC Blog
  • Resources
    • Links
    • Publications
    • Documents
    • Templates
    • Company Media
    • Login
  • Contact
GBC - Global BioClinical

 

  • Home
  • Company
    • Company Overview
    • Management Team
    • Director’s Message
    • “The Small Clinical Research Organization (CRO) Advantage”
    • Core Values
    • Memberships
    • Careers
    • Contact
  • Services
    • Consulting
      • Organizational Consulting
        • Organizations GBC Serves
      • Project Management
      • Quality Management
        • QMS Development
        • Audit Services
          • Organizations GBC Audits
      • Regulatory Support
      • Medical & Technical Writing
      • Medical & Scientific Liaison
    • Business
      • Business Intelligence
      • Strategic Alliances
        • Alliance Evaluation
        • Alliance Management
      • Business Development
      • Risk Management
      • Human Capital
    • Trials
      • Trial Strategy & Design
        • Types of Studies
        • Therapeutic Areas
        • Trial Globalization
      • Trial Preparation
      • Trial Launch
      • Site Management
      • Monitoring
      • Data Management
      • Study Supply Logistics
      • Adaptive Transition
      • Trial Close Out
    • Biospecimens
      • Sourcing
        • Common Indications
        • Common Formats
      • Biospecimen Management
      • Biorepository Management
      • Biorepository Accreditation
      • Cost Recovery
      • Tissue Research
  • Partners
    • Clients
    • Investigators
    • Industry Colleagues
  • Register
    • Registration
  • News & Events
    • In Vitro Diagnostics – IVD News
    • Press Releases
    • Events
    • GBC Blog
  • Resources
    • Links
    • Publications
    • Documents
    • Templates
    • Company Media
    • Login
  • Contact

Archives

NEWS

  • Teal Health Completes Clinical Trial at Record Speed and Receives FDA Breakthrough Designation for Its At-Home Cervical Cancer Screening Device, the Teal Wand™
  • OpGen Submits De Novo Request to the U.S. FDA for Unyvero Urinary Tract Infection (UTI) Panel
  • OpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection (UTI) Panel
  • InfanDx Tackles Early Detection of Hypoxic Ischemic Encephalopathy

GBC BLOG

  • Biotech firm Recursion to Buy Smaller Peer Exscientia
  • Fred Hutch Unveils Results of New Blood Test That Detects Colon Cancer
  • Bacteria Subtype Linked to Growth in Up to 50% of Human Colorectal Cancers
  • KLAS Research U.S. Digital Pathology Report Confirms Philips As One of The Industry’s Leading Players

AMP Members Reiterate Position on LDTs

November 18, 2014

Select link below to view original article:

https://www.genomeweb.com/clinical-genomics/amp-members-reiterate-position-ldt-regulation-questions-fda-suggest-confusion-re

Posted in GBC Blog

113 Cherry Street, Suite #80042
Seattle, WA 98104-2205 USA
PHONE: +1 888 659 1221
FAX: +1 206 299 9895
EMAIL: info@globalbioclinical.com

Visit Us On FacebookVisit Us On TwitterVisit Us On Linkedin
Copyright © GLOBAL BIOCLINICAL
Scroll To Top